Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer
about
Psychometric analysis of the Patient Assessment of Own Functioning Inventory in women with breast cancer.The impact of cognitive function on medication management: three studies.The Working Memory and Dorsolateral Prefrontal-Hippocampal Functional Connectivity Changes in Long-Term Survival Breast Cancer Patients Treated with Tamoxifen.Brain sex matters: estrogen in cognition and Alzheimer's diseaseStatus of adjuvant endocrine therapy for breast cancer.Managing aromatase inhibitors in breast cancer survivors: not just for oncologistsCognitive effects of cancer systemic therapy: implications for the care of older patients and survivors.Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial.The Dark Side of the Moon - the Side Effects of Therapy in a Dynamic Era of Breast Cancer Management.Cognitive Effects of Systemic Therapy in Patients with Breast CancerI'm so tired: biological and genetic mechanisms of cancer-related fatigueDo aromatase inhibitors have adverse effects on cognitive function?Management of Cancer-related Cognitive Dysfunction-Conceptualization Challenges and Implications for Clinical Research and Practice.Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatmentEffects of aromatase inhibition versus gonadectomy on hippocampal complex amyloid pathology in triple transgenic miceEffects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in miceCognitive changes associated with endocrine therapy for breast cancer.Clinical utility of exemestane in the treatment of breast cancerNeeds assessment of cancer survivors in ConnecticutEvaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy.Patterns of change in cognitive function with anastrozole therapy.Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer.Identification and prioritization of candidate genes for symptom variability in breast cancer survivors based on disease characteristics at the cellular level.Effect of endocrine therapy on quality of life and cognitive functions in patients with breast cancer.Does lifetime exposure to hormones predict pretreatment cognitive function in women before adjuvant therapy for breast cancer?Long-term efficacy and safety of letrozole for the adjuvant treatment of early breast cancer in postmenopausal women: a reviewThe effect of a community-based exercise intervention on symptoms and quality of life.The expanding use of third-generation aromatase inhibitors: what the general internist needs to knowEffects of tamoxifen and raloxifene on memory and other cognitive abilities: cognition in the study of tamoxifen and raloxifene.Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments.'Chemobrain': concentration and memory effects in people receiving chemotherapy - a descriptive phenomenological study.Current role and safety profile of aromatase inhibitors in early breast cancer.Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors.Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.Clearing the air: a review of our current understanding of "chemo fog".Cognitive dysfunction after chemotherapy for breast cancer.Intriguing roles of hippocampus-synthesized 17β-estradiol in the modulation of hippocampal synaptic plasticity.Cognitive effects of endocrine therapy for breast cancer: keep calm and carry on?Can Exercise Ameliorate Aromatase Inhibitor-Induced Cognitive Decline in Breast Cancer Patients?
P2860
Q33570551-C3D60B21-089B-40D5-BAF9-D315B3E0D836Q33596657-F0918FA7-AFF1-449F-8162-3F5DDE41DCA4Q33636517-19C7C26D-E8FC-4F94-B7C7-D04F7C43CAA6Q33693268-626C65BA-4B87-4C84-B5D9-DECE3EF935E9Q33739138-762CE6A0-65C4-430D-B441-DAF0C1FB2F2EQ33884184-A86CF23C-C0A5-4601-A529-D17848560A77Q34031141-1B40F9B1-5554-4347-8B52-C7E19D9B8CA1Q34065038-CEA9DFA2-A769-4698-ABC9-20289400E229Q34095802-C87223B1-6A4F-491D-99E1-D4F164C87C6AQ34095832-42EF8CD0-64EA-42DA-BF42-515ABD907D27Q34543971-79A71EA8-A5CA-4B9F-BD59-D6C3B328A587Q35029513-3F1286CA-4AB9-45F0-9228-35C4356FBDF6Q35427635-6F35A9EA-C8DB-48F4-9647-91F7228AD803Q35535907-9B1FF1F8-2D4B-442D-824D-E3B18941ADD5Q35577375-70E21B55-DE32-4637-9425-9F1F0D087B6EQ35644334-F5FD6E24-23EB-42C5-A01B-A506FCAEF844Q35660927-8F696DDE-636E-4421-8DD4-7E94F6D9F45AQ35683807-84B9EFA3-C36A-4369-911F-C53795F0517CQ35742776-F97D033F-3089-4D02-809C-EE8FE174BE34Q35846781-9AFDA825-0849-4510-BB8E-59162727C00EQ35883135-49BA7E50-C950-4557-9FE6-35F2B59FD128Q35949546-17CA9221-5DCE-41E0-9918-6F6A9AEE6870Q36684067-F8A9D962-8EE6-4B0E-B204-0B4A603193D9Q36932994-9A075D8D-B9D6-4D9A-AEB6-9A3EBFC19AA1Q37100148-CD16AA48-4F3B-43B8-8CBD-1F18E63B7C6EQ37354647-4C24E3BA-7257-430C-8A15-3242C86347E5Q37374507-5982A240-E4DB-4E9C-9BA9-9E8B1A899961Q37390076-6B89F063-E7EF-47EE-9FC7-7A43ADAE5465Q37412283-DA9281F8-B6B0-42EA-AA7F-7A9254DD9977Q37431101-8B25D7F1-6DDB-46D0-A5B6-D64A54367E08Q37585300-882D3A38-B69B-4B85-8F42-B337DB90A339Q37858658-009A775D-9F52-4F3B-A67B-F74208C26F37Q37931895-F17904A1-98A5-4BC3-BDBE-07CD66BAEDE6Q37931900-4006B20A-1569-4883-A073-AC1F17AF600BQ37976412-9E4C39BC-1948-4773-B331-49ACC80A4C29Q38088668-F532A0B5-460E-42B6-9F8F-02B90835E5A6Q38198215-FCAA1B64-60EE-40E9-9DF8-5E824F2A7127Q38204317-7F71664D-D6D4-4752-A5AD-176088B9FC93Q38551397-E0168746-1873-4F71-B649-0F43063A39B2Q38557077-6F5B107F-F5AB-4F74-988F-2EFFD90F61E8
P2860
Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Memory impairments with adjuva ...... with early-stage breast cancer
@ast
Memory impairments with adjuva ...... with early-stage breast cancer
@en
Memory impairments with adjuva ...... with early-stage breast cancer
@nl
type
label
Memory impairments with adjuva ...... with early-stage breast cancer
@ast
Memory impairments with adjuva ...... with early-stage breast cancer
@en
Memory impairments with adjuva ...... with early-stage breast cancer
@nl
prefLabel
Memory impairments with adjuva ...... with early-stage breast cancer
@ast
Memory impairments with adjuva ...... with early-stage breast cancer
@en
Memory impairments with adjuva ...... with early-stage breast cancer
@nl
P2093
P2860
P3181
P1433
P1476
Memory impairments with adjuva ...... with early-stage breast cancer
@en
P2093
Adam M Brufsky
Catherine M Bender
Frances E Casillo
Priya Rastogi
Sarah L Berga
Susan M Sereika
Victor G Vogel
P2860
P304
P3181
P356
10.1097/GME.0B013E318148B28B
P407
P577
2007-11-01T00:00:00Z